Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Psychiatric symptoms at the end of life, part 2: Depressive disorder

by jlohrconsulting | Sep 12, 2025 | Uncategorized

MMW Fortschr Med. 2025 Sep;167(15):60-62. doi: 10.1007/s15006-025-5202-2. ABSTRACT The prevalence of depression, including adjustment disorders, in palliative care ranges from 20% to 40%. Depressive symptoms are often not reported spontaneously and must be classified...

Prevalence and risk factors of suicidal ideation amongst unaccompanied young refugees: a machine learning approach

by jlohrconsulting | Sep 12, 2025 | Uncategorized

Eur Child Adolesc Psychiatry. 2025 Sep 12. doi: 10.1007/s00787-025-02828-0. Online ahead of print. ABSTRACT BACKGROUND: Suicidality is a major public health concern worldwide. Evidence on the prevalence and risk factors of suicidality amongst unaccompanied young...

Association of School-Based Health Center Availability With Child Mental Health Outcomes

by jlohrconsulting | Sep 12, 2025 | Uncategorized

Health Serv Res. 2025 Sep 11:e70042. doi: 10.1111/1475-6773.70042. Online ahead of print. ABSTRACT OBJECTIVE: To estimate changes in student mental health outcomes after the adoption of a school-based health center (SBHC). STUDY SETTING/DESIGN: Using a retrospective,...

Analysis of the Therapeutic Potential of Astragalin: Insights into Target Interactions and Mechanisms

by jlohrconsulting | Sep 11, 2025 | Uncategorized

Xenobiotica. 2025 Sep 11:1-25. doi: 10.1080/00498254.2025.2559962. Online ahead of print. ABSTRACT Astragalin (AST), a flavonoid, shows promise for neurodegenerative diseases like Parkinson’s disease (PD), cognitive impairment (CI), and depression. However, its...

Machine learning algorithms and their predictive accuracy for suicide and self-harm: Systematic review and meta-analysis

by jlohrconsulting | Sep 11, 2025 | Uncategorized

PLoS Med. 2025 Sep 11;22(9):e1004581. doi: 10.1371/journal.pmed.1004581. eCollection 2025 Sep. ABSTRACT BACKGROUND: There has been rapid expansion in the development of machine learning algorithms to predict suicidal behaviours. To test the accuracy of these...

Happy or not? An investigative study on well-being and anhedonia in everyday life

by jlohrconsulting | Sep 11, 2025 | Uncategorized

PLoS One. 2025 Sep 11;20(9):e0331769. doi: 10.1371/journal.pone.0331769. eCollection 2025. ABSTRACT Anhedonia, the inability to experience pleasure or interest in activities, is a key symptom across various psychiatric disorders, including depression. It links to poor...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments